Stevanato group reports third quarter 2023 financial results

Piombino dese, italy--(business wire)--stevanato group s.p.a. (nyse: stvn), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the third quarter of 2023. third quarter 2023 highlights (compared with the same period last year) third quarter revenue increased 11% to €271.4 million. revenue from high-value solutions increased to 32% of total revenue. net.
STVN Ratings Summary
STVN Quant Ranking